Journal of Pharmacogenomics & Pharmacoproteomics

Journal of Pharmacogenomics & Pharmacoproteomics
Open Access

ISSN: 2153-0645

+32-466-902163

Citations Report

Citations Report - Journal of Pharmacogenomics & Pharmacoproteomics [149 Articles]

The articles published in Journal of Pharmacogenomics & Pharmacoproteomics have been cited 149 times by eminent researchers all around the world. Following is the list of articles that have cited the articles published in Journal of Pharmacogenomics & Pharmacoproteomics.

Morales-Vásquez, Lilliana, et al. "Demographics, clinical characteristics, IFNL3-and IFNL4-polymorphisms in a cohort of hepatitis C patients from Puerto Rico." Puerto Rico health sciences journal 33.4 (2014): 177.

Duconge, J. "Population heterogeneity and genomic admixture: relevance for global pharmacogenetics." J. Pharmacogenom. Pharmacoproteomics 5 (2014): 5.

Valentín, Isa I., et al. "Pharmacogenetic association study of warfarin safety endpoints in Puerto Ricans." Puerto Rico health sciences journal 33.3 (2014): 97.

Nishant, T., et al. "Pharmacogenomics-Personalized treatment of cancer, diabetes and cardiovascular diseases." J Pharmacogenomics Pharmacoproteomics 2 (2011): 107.

Duconge, Jorge, et al. "A novel admixture-based pharmacogenetic approach to refine warfarin dosing in Caribbean Hispanics." PloS one 11.1 (2016): e0145480.

Duconge, Jorge. "Why admixture matters in genetically-guided therapy: Missed targets in the COAG and EU-PACT trials." Puerto Rico health sciences journal 34.3 (2015): 175.

Claudio-Campos, Karla, et al. "Pharmacogenetics of drug-metabolizing enzymes in US Hispanics." Drug metabolism and personalized therapy 30.2 (2015): 87-105.

Orengo-Mercado, Carmelo, et al. "Frequencies of functional polymorphisms in three pharmacokinetic genes of clinical interest within the admixed Puerto Rican population." Journal of pharmacogenomics & pharmacoproteomics 4.113 (2013).

Arias, Albert J., and R. Andrew Sewell. "Pharmacogenetically driven treatments for alcoholism." CNS drugs 26.6 (2012): 461-476.

Nishant, T., et al. "Pharmacogenomics-Personalized treatment of cancer, diabetes and cardiovascular diseases." J Pharmacogenomics Pharmacoproteomics 2 (2011): 107.

Shimoyama, Shouji. "Chemotherapy for Gastric Cancer—What Comes Next?." Updates on Cancer Treatment. InTech, 2015.

Praveenya, P., et al. "Antibiotic Resistance Creating New Epoch." J Bacteriol Parasitol 3.131 (2012): 2.

Naga Anusha, P., A. Siddiqui, and A. Hima Bindu. "Immuno Defense Mechanism against Tumors." J Cancer Sci Ther S 17 (2011): 2.

Nishant, T., et al. "Pharmacogenomics-Personalized treatment of cancer, diabetes and cardiovascular diseases." J Pharmacogenomics Pharmacoproteomics 2 (2011): 107.76.pdf

Sultana, Shabana. "Research and Reviews: Journal of Pharmacy and Pharmaceutical Sciences."

Eckstein, Lisa. "Searching for a role for genomics in the right to health." Advancing the Human Right to Health (2013): 391.

Bushyakanist, Asalaysa, et al. "The use of pharmacogenetics in clinical practice for the treatment of individuals with HIV infection in Thailand." Pharmacogenomics and personalized medicine 8 (2015): 163.

Plumpton, Catrin O., et al. "A systematic review of economic evaluations of pharmacogenetic testing for prevention of adverse drug reactions." PharmacoEconomics 34.8 (2016): 771-793.

Zuniga, José M., Stephen P. Marks, and Lawrence O. Gostin, eds. Advancing the human right to health. OUP Oxford, 2013.

Rattanavipapong, Waranya, et al. "Economic evaluation of HLA‐B* 15: 02 screening for carbamazepine‐induced severe adverse drug reactions in Thailand." Epilepsia 54.9 (2013): 1628-1638.

Top